ID   DAPA_ECOLI              Reviewed;         292 AA.
AC   P0A6L2; P05640; P78223;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 1.
DT   15-MAR-2017, entry version 111.
DE   RecName: Full=4-hydroxy-tetrahydrodipicolinate synthase {ECO:0000255|HAMAP-Rule:MF_00418};
DE            Short=HTPA synthase {ECO:0000255|HAMAP-Rule:MF_00418};
DE            EC=4.3.3.7 {ECO:0000255|HAMAP-Rule:MF_00418};
GN   Name=dapA {ECO:0000255|HAMAP-Rule:MF_00418};
GN   OrderedLocusNames=b2478, JW2463;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3514578; DOI=10.1128/jb.166.1.297-300.1986;
RA   Richaud F., Richaud C., Ratet P., Patte J.-C.;
RT   "Chromosomal location and nucleotide sequence of the Escherichia coli
RT   dapA gene.";
RL   J. Bacteriol. 166:297-300(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9205837; DOI=10.1093/dnares/4.2.91;
RA   Yamamoto Y., Aiba H., Baba T., Hayashi K., Inada T., Isono K.,
RA   Itoh T., Kimura S., Kitagawa M., Makino K., Miki T., Mitsuhashi N.,
RA   Mizobuchi K., Mori H., Nakade S., Nakamura Y., Nashimoto H.,
RA   Oshima T., Oyama S., Saito N., Sampei G., Satoh Y., Sivasundaram S.,
RA   Tagami H., Takahashi H., Takeda J., Takemoto K., Uehara K., Wada C.,
RA   Yamagata S., Horiuchi T.;
RT   "Construction of a contiguous 874-kb sequence of the Escherichia coli-
RT   K12 genome corresponding to 50.0-68.8 min on the linkage map and
RT   analysis of its sequence features.";
RL   DNA Res. 4:91-113(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   PROTEIN SEQUENCE OF 1-11.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RA   Frutiger S., Hughes G.J., Pasquali C., Hochstrasser D.F.;
RL   Submitted (FEB-1996) to UniProtKB.
RN   [6]
RP   PROTEIN SEQUENCE OF 1-12.
RC   STRAIN=K12 / EMG2;
RX   PubMed=9298646; DOI=10.1002/elps.1150180807;
RA   Link A.J., Robison K., Church G.M.;
RT   "Comparing the predicted and observed properties of proteins encoded
RT   in the genome of Escherichia coli K-12.";
RL   Electrophoresis 18:1259-1313(1997).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-4.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9600841; DOI=10.1006/jmbi.1998.1726;
RA   Wilkins M.R., Gasteiger E., Tonella L., Ou K., Tyler M.,
RA   Sanchez J.-C., Gooley A.A., Walsh B.J., Bairoch A., Appel R.D.,
RA   Williams K.L., Hochstrasser D.F.;
RT   "Protein identification with N and C-terminal sequence tags in
RT   proteome projects.";
RL   J. Mol. Biol. 278:599-608(1998).
RN   [8]
RP   PROTEIN SEQUENCE OF 156-167, AND ACTIVE SITE.
RX   PubMed=1463470; DOI=10.1042/bj2880691;
RA   Laber B., Gomis-Rueth F.-X., Romao M.J., Huber R.;
RT   "Escherichia coli dihydrodipicolinate synthase. Identification of the
RT   active site and crystallization.";
RL   Biochem. J. 288:691-695(1992).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 288-292.
RC   STRAIN=K12;
RX   PubMed=2120198; DOI=10.1128/jb.172.10.6035-6041.1990;
RA   Tiedemann A.A., Demarini D.J., Parker J., Smith J.M.;
RT   "DNA sequence of the purC gene encoding 5'-phosphoribosyl-5-
RT   aminoimidazole-4-N-succinocarboxamide synthetase and organization of
RT   the dapA-purC region of Escherichia coli K-12.";
RL   J. Bacteriol. 172:6035-6041(1990).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 288-292.
RC   STRAIN=K12;
RX   PubMed=1885529; DOI=10.1128/jb.173.17.5523-5531.1991;
RA   Bouvier J., Pugsley A.P., Stragier P.;
RT   "A gene for a new lipoprotein in the dapA-purC interval of the
RT   Escherichia coli chromosome.";
RL   J. Bacteriol. 173:5523-5531(1991).
RN   [11]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R.,
RA   Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [12]
RP   ENZYME REGULATION.
RX   PubMed=9048556; DOI=10.1021/bi962264x;
RA   Karsten W.E.;
RT   "Dihydrodipicolinate synthase from Escherichia coli: pH dependent
RT   changes in the kinetic mechanism and kinetic mechanism of allosteric
RT   inhibition by L-lysine.";
RL   Biochemistry 36:1730-1739(1997).
RN   [13]
RP   ENZYME REGULATION, KINETIC PARAMETERS, AND MASS SPECTROMETRY.
RX   PubMed=14580236; DOI=10.1042/BJ20031389;
RA   Dobson R.C., Gerrard J.A., Pearce F.G.;
RT   "Dihydrodipicolinate synthase is not inhibited by its substrate, (S)-
RT   aspartate beta-semialdehyde.";
RL   Biochem. J. 377:757-762(2004).
RN   [14]
RP   SYNTHETIC INHIBITORS.
RX   PubMed=18977662; DOI=10.1016/j.bmc.2008.10.026;
RA   Boughton B.A., Griffin M.D., O'Donnell P.A., Dobson R.C.,
RA   Perugini M.A., Gerrard J.A., Hutton C.A.;
RT   "Irreversible inhibition of dihydrodipicolinate synthase by 4-oxo-
RT   heptenedioic acid analogues.";
RL   Bioorg. Med. Chem. 16:9975-9983(2008).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, IDENTIFICATION OF HTPA AS REACTION
RP   PRODUCT, AND SUBSTRATE SPECIFICITY.
RX   PubMed=20503968; DOI=10.1021/jm100349s;
RA   Devenish S.R., Blunt J.W., Gerrard J.A.;
RT   "NMR studies uncover alternate substrates for dihydrodipicolinate
RT   synthase and suggest that dihydrodipicolinate reductase is also a
RT   dehydratase.";
RL   J. Med. Chem. 53:4808-4812(2010).
RN   [16]
RP   SYNTHETIC INHIBITORS.
RX   PubMed=22386717; DOI=10.1016/j.bmc.2012.01.045;
RA   Boughton B.A., Hor L., Gerrard J.A., Hutton C.A.;
RT   "1,3-Phenylene bis(ketoacid) derivatives as inhibitors of Escherichia
RT   coli dihydrodipicolinate synthase.";
RL   Bioorg. Med. Chem. 20:2419-2426(2012).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=7853400; DOI=10.1006/jmbi.1994.0078;
RA   Mirwaldt C., Korndoerfer I., Huber R.;
RT   "The crystal structure of dihydrodipicolinate synthase from
RT   Escherichia coli at 2.5-A resolution.";
RL   J. Mol. Biol. 246:227-239(1995).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS), FUNCTION, CATALYTIC ACTIVITY,
RP   IDENTIFICATION OF HTPA AS REACTION PRODUCT, AND CATALYTIC MECHANISM.
RX   PubMed=8993314; DOI=10.1021/bi962272d;
RA   Blicking S., Renner C., Laber B., Pohlenz H.-D., Holak T.A., Huber R.;
RT   "Reaction mechanism of Escherichia coli dihydrodipicolinate synthase
RT   investigated by X-ray crystallography and NMR spectroscopy.";
RL   Biochemistry 36:24-33(1997).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF MUTANTS VAL-44; PHE-107 AND
RP   PHE-133, KINETIC PARAMETERS, MUTAGENESIS OF THR-44; TYR-107 AND
RP   TYR-133, AND REACTION MECHANISM.
RX   PubMed=15066435; DOI=10.1016/j.jmb.2004.02.060;
RA   Dobson R.C.J., Valegaard K., Gerrard J.A.;
RT   "The crystal structure of three site-directed mutants of Escherichia
RT   coli dihydrodipicolinate synthase: further evidence for a catalytic
RT   triad.";
RL   J. Mol. Biol. 338:329-339(2004).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF APOENZYME AND IN COMPLEX WITH
RP   ALLOSTERIC INHIBITOR (S)-LYSINE, AND SUBUNIT.
RX   PubMed=16041077; DOI=10.1107/S0907444905016318;
RA   Dobson R.C.J., Griffin M.D.W., Jameson G.B., Gerrard J.A.;
RT   "The crystal structures of native and (S)-lysine-bound
RT   dihydrodipicolinate synthase from Escherichia coli with improved
RT   resolution show new features of biological significance.";
RL   Acta Crystallogr. D 61:1116-1124(2005).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF MUTANTS ALA-138 AND HIS-138,
RP   AND MUTAGENESIS OF ARG-138.
RX   PubMed=16185069; DOI=10.1021/bi051281w;
RA   Dobson R.C.J., Devenish S.R.A., Turner L.A., Clifford V.R.,
RA   Pearce F.G., Jameson G.B., Gerrard J.A.;
RT   "Role of arginine 138 in the catalysis and regulation of Escherichia
RT   coli dihydrodipicolinate synthase.";
RL   Biochemistry 44:13007-13013(2005).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH LYSINE
RP   INHIBITOR.
RA   Devenish S.R.A., Dobson R.C.J., Jameson G.B., Gerrard J.A.;
RT   "The co-crystallisation of (S)-lysine-bound dihydrodipicolinate
RT   synthase from E. coli indicates that domain movements are not
RT   responsible for (S)-lysine inhibition.";
RL   Submitted (AUG-2005) to the PDB data bank.
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS).
RX   PubMed=19052357; DOI=10.1107/S1744309108033654;
RA   Devenish S.R., Gerrard J.A., Jameson G.B., Dobson R.C.;
RT   "The high-resolution structure of dihydrodipicolinate synthase from
RT   Escherichia coli bound to its first substrate, pyruvate.";
RL   Acta Crystallogr. F 64:1092-1095(2008).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF MUTANT TRP-107, SUBUNIT, AND
RP   MUTAGENESIS OF TYR-107.
RX   PubMed=18937497; DOI=10.1021/bi801094t;
RA   Pearce F.G., Dobson R.C., Weber A., Lane L.A., McCammon M.G.,
RA   Squire M.A., Perugini M.A., Jameson G.B., Robinson C.V., Gerrard J.A.;
RT   "Mutating the tight-dimer interface of dihydrodipicolinate synthase
RT   disrupts the enzyme quaternary structure: toward a monomeric enzyme.";
RL   Biochemistry 47:12108-12117(2008).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF MUTANT TYR-197, SUBUNIT, AND
RP   MUTAGENESIS OF LEU-197.
RX   PubMed=18556019; DOI=10.1016/j.jmb.2008.05.038;
RA   Griffin M.D., Dobson R.C., Pearce F.G., Antonio L., Whitten A.E.,
RA   Liew C.K., Mackay J.P., Trewhella J., Jameson G.B., Perugini M.A.,
RA   Gerrard J.A.;
RT   "Evolution of quaternary structure in a homotetrameric enzyme.";
RL   J. Mol. Biol. 380:691-703(2008).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS), ENZYME REGULATION, AND MASS
RP   SPECTROMETRY.
RX   PubMed=18787203; DOI=10.1110/ps.037440.108;
RA   Dobson R.C., Griffin M.D., Devenish S.R., Pearce F.G., Hutton C.A.,
RA   Gerrard J.A., Jameson G.B., Perugini M.A.;
RT   "Conserved main-chain peptide distortions: a proposed role for Ile203
RT   in catalysis by dihydrodipicolinate synthase.";
RL   Protein Sci. 17:2080-2090(2008).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF MUTANT SER-44, MUTAGENESIS
RP   OF THR-44, ACTIVE SITES, AND REACTION MECHANISM.
RX   PubMed=19505526; DOI=10.1016/j.biochi.2009.05.013;
RA   Dobson R.C., Perugini M.A., Jameson G.B., Gerrard J.A.;
RT   "Specificity versus catalytic potency: The role of threonine 44 in
RT   Escherichia coli dihydrodipicolinate synthase mediated catalysis.";
RL   Biochimie 91:1036-1044(2009).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF MUTANTS ALA-161 AND ARG-161
RP   OF NATIVE PROTEIN AND IN COMPLEX WITH PYRUVATE, AND MUTAGENESIS OF
RP   LYS-161.
RX   PubMed=20353808; DOI=10.1016/j.biochi.2010.03.004;
RA   Soares da Costa T.P., Muscroft-Taylor A.C., Dobson R.C.,
RA   Devenish S.R., Jameson G.B., Gerrard J.A.;
RT   "How essential is the 'essential' active-site lysine in
RT   dihydrodipicolinate synthase?";
RL   Biochimie 92:837-845(2010).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) IN COMPLEX WITH PYRUVATE AND
RP   SUBSTRATE ANALOG INHIBITOR.
RX   PubMed=22552955; DOI=10.1002/prot.24106;
RA   Boughton B.A., Dobson R.C., Hutton C.A.;
RT   "The crystal structure of dihydrodipicolinate synthase from
RT   Escherichia coli with bound pyruvate and succinic acid semialdehyde:
RT   unambiguous resolution of the stereochemistry of the condensation
RT   product.";
RL   Proteins 80:2117-2122(2012).
CC   -!- FUNCTION: Catalyzes the condensation of (S)-aspartate-beta-
CC       semialdehyde [(S)-ASA] and pyruvate to 4-hydroxy-
CC       tetrahydrodipicolinate (HTPA). {ECO:0000255|HAMAP-Rule:MF_00418,
CC       ECO:0000269|PubMed:20503968, ECO:0000269|PubMed:8993314}.
CC   -!- CATALYTIC ACTIVITY: Pyruvate + L-aspartate-4-semialdehyde = (4S)-
CC       4-hydroxy-2,3,4,5-tetrahydro-(2S)-dipicolinate + H(2)O.
CC       {ECO:0000255|HAMAP-Rule:MF_00418, ECO:0000269|PubMed:20503968,
CC       ECO:0000269|PubMed:8993314}.
CC   -!- ENZYME REGULATION: Is allosterically regulated by the feedback
CC       inhibitor (S)-lysine. Is inhibited by pyruvate analogs such as 3-
CC       fluoropyruvate, 2-ketobutyrate, glyoxylate, and beta-
CC       hydroxypyruvate. Is not inhibited by its substrate, (S)-ASA.
CC       {ECO:0000269|PubMed:14580236, ECO:0000269|PubMed:18787203,
CC       ECO:0000269|PubMed:9048556}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.26 mM for pyruvate {ECO:0000269|PubMed:14580236,
CC         ECO:0000269|PubMed:15066435};
CC         KM=0.11 mM for L-aspartate-4-semialdehyde
CC         {ECO:0000269|PubMed:14580236, ECO:0000269|PubMed:15066435};
CC         Vmax=0.58 umol/sec/mg enzyme {ECO:0000269|PubMed:14580236,
CC         ECO:0000269|PubMed:15066435};
CC         Note=kcat is 124 sec(-1).;
CC   -!- PATHWAY: Amino-acid biosynthesis; L-lysine biosynthesis via DAP
CC       pathway; (S)-tetrahydrodipicolinate from L-aspartate: step 3/4.
CC       {ECO:0000255|HAMAP-Rule:MF_00418}.
CC   -!- SUBUNIT: Homotetramer; dimer of dimers. {ECO:0000255|HAMAP-
CC       Rule:MF_00418, ECO:0000269|PubMed:16041077,
CC       ECO:0000269|PubMed:18556019, ECO:0000269|PubMed:18937497,
CC       ECO:0000269|PubMed:20353808, ECO:0000269|PubMed:22552955,
CC       ECO:0000269|Ref.22}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-907527, EBI-907527;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- MASS SPECTROMETRY: Mass=31272; Mass_error=1; Method=Electrospray;
CC       Range=1-292; Evidence={ECO:0000269|PubMed:14580236};
CC   -!- MASS SPECTROMETRY: Mass=31270; Method=Electrospray; Range=1-292;
CC       Evidence={ECO:0000269|PubMed:18787203};
CC   -!- SIMILARITY: Belongs to the DapA family. {ECO:0000255|HAMAP-
CC       Rule:MF_00418}.
CC   -!- CAUTION: Was originally thought to be a dihydrodipicolinate
CC       synthase (DHDPS), catalyzing the condensation of (S)-aspartate-
CC       beta-semialdehyde [(S)-ASA] and pyruvate to dihydrodipicolinate
CC       (DHDP). However, it was shown that the product of the enzymatic
CC       reaction is not dihydrodipicolinate but in fact (4S)-4-hydroxy-
CC       2,3,4,5-tetrahydro-(2S)-dipicolinic acid (HTPA), and that the
CC       consecutive dehydration reaction leading to DHDP is not
CC       spontaneous but catalyzed by DapB (PubMed:8993314,
CC       PubMed:20503968). {ECO:0000305|PubMed:20503968,
CC       ECO:0000305|PubMed:8993314}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M12844; AAA23665.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75531.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA16355.1; -; Genomic_DNA.
DR   EMBL; M33928; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X57402; CAA40660.1; -; Genomic_DNA.
DR   PIR; E65023; SYECDP.
DR   RefSeq; NP_416973.1; NC_000913.3.
DR   RefSeq; WP_001311023.1; NZ_LN832404.1.
DR   PDB; 1DHP; X-ray; 2.30 A; A/B=1-292.
DR   PDB; 1S5T; X-ray; 2.30 A; A/B=1-292.
DR   PDB; 1S5V; X-ray; 2.35 A; A/B=1-292.
DR   PDB; 1S5W; X-ray; 2.32 A; A/B=1-292.
DR   PDB; 1YXC; X-ray; 1.90 A; A/B=1-292.
DR   PDB; 1YXD; X-ray; 2.00 A; A/B=1-292.
DR   PDB; 2A6L; X-ray; 2.05 A; A/B=1-292.
DR   PDB; 2A6N; X-ray; 1.94 A; A/B=1-292.
DR   PDB; 2ATS; X-ray; 1.90 A; A/B=1-292.
DR   PDB; 2OJP; X-ray; 1.70 A; A/B=1-292.
DR   PDB; 2PUR; X-ray; 1.70 A; A/B=1-292.
DR   PDB; 3C0J; X-ray; 2.40 A; A/B=1-292.
DR   PDB; 3DEN; X-ray; 2.20 A; A/B=1-292.
DR   PDB; 3DU0; X-ray; 2.00 A; A/B=1-292.
DR   PDB; 3I7Q; X-ray; 2.00 A; A/B=1-292.
DR   PDB; 3I7R; X-ray; 2.10 A; A/B=1-292.
DR   PDB; 3I7S; X-ray; 2.30 A; A/B=1-292.
DR   PDB; 4EOU; X-ray; 2.30 A; A/B=1-292.
DR   PDB; 5T26; X-ray; 2.10 A; A/B=1-292.
DR   PDBsum; 1DHP; -.
DR   PDBsum; 1S5T; -.
DR   PDBsum; 1S5V; -.
DR   PDBsum; 1S5W; -.
DR   PDBsum; 1YXC; -.
DR   PDBsum; 1YXD; -.
DR   PDBsum; 2A6L; -.
DR   PDBsum; 2A6N; -.
DR   PDBsum; 2ATS; -.
DR   PDBsum; 2OJP; -.
DR   PDBsum; 2PUR; -.
DR   PDBsum; 3C0J; -.
DR   PDBsum; 3DEN; -.
DR   PDBsum; 3DU0; -.
DR   PDBsum; 3I7Q; -.
DR   PDBsum; 3I7R; -.
DR   PDBsum; 3I7S; -.
DR   PDBsum; 4EOU; -.
DR   PDBsum; 5T26; -.
DR   ProteinModelPortal; P0A6L2; -.
DR   SMR; P0A6L2; -.
DR   IntAct; P0A6L2; 3.
DR   STRING; 511145.b2478; -.
DR   BindingDB; P0A6L2; -.
DR   ChEMBL; CHEMBL4083; -.
DR   SWISS-2DPAGE; P0A6L2; -.
DR   EPD; P0A6L2; -.
DR   PaxDb; P0A6L2; -.
DR   PRIDE; P0A6L2; -.
DR   EnsemblBacteria; AAC75531; AAC75531; b2478.
DR   EnsemblBacteria; BAA16355; BAA16355; BAA16355.
DR   GeneID; 946952; -.
DR   KEGG; ecj:JW2463; -.
DR   KEGG; eco:b2478; -.
DR   PATRIC; 32120343; VBIEscCol129921_2574.
DR   EchoBASE; EB0201; -.
DR   EcoGene; EG10205; dapA.
DR   eggNOG; ENOG4105CDP; Bacteria.
DR   eggNOG; COG0329; LUCA.
DR   HOGENOM; HOG000173604; -.
DR   InParanoid; P0A6L2; -.
DR   KO; K01714; -.
DR   OMA; GMDACVP; -.
DR   PhylomeDB; P0A6L2; -.
DR   BioCyc; EcoCyc:DIHYDRODIPICSYN-MONOMER; -.
DR   BioCyc; MetaCyc:DIHYDRODIPICSYN-MONOMER; -.
DR   BRENDA; 4.3.3.7; 2026.
DR   UniPathway; UPA00034; UER00017.
DR   EvolutionaryTrace; P0A6L2; -.
DR   PRO; PR:P0A6L2; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0008840; F:4-hydroxy-tetrahydrodipicolinate synthase; IDA:EcoCyc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019877; P:diaminopimelate biosynthetic process; IDA:EcoliWiki.
DR   GO; GO:0009089; P:lysine biosynthetic process via diaminopimelate; IEA:UniProtKB-UniPathway.
DR   CDD; cd00950; DHDPS; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   HAMAP; MF_00418; DapA; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR005263; DapA.
DR   InterPro; IPR002220; DapA-like.
DR   InterPro; IPR020625; Schiff_base-form_aldolases_AS.
DR   InterPro; IPR020624; Schiff_base-form_aldolases_CS.
DR   PANTHER; PTHR12128; PTHR12128; 1.
DR   Pfam; PF00701; DHDPS; 1.
DR   PIRSF; PIRSF001365; DHDPS; 1.
DR   PRINTS; PR00146; DHPICSNTHASE.
DR   SMART; SM01130; DHDPS; 1.
DR   TIGRFAMs; TIGR00674; dapA; 1.
DR   PROSITE; PS00665; DHDPS_1; 1.
DR   PROSITE; PS00666; DHDPS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; Amino-acid biosynthesis;
KW   Complete proteome; Cytoplasm; Diaminopimelate biosynthesis;
KW   Direct protein sequencing; Lyase; Lysine biosynthesis;
KW   Reference proteome; Schiff base.
FT   CHAIN         1    292       4-hydroxy-tetrahydrodipicolinate
FT                                synthase.
FT                                /FTId=PRO_0000103110.
FT   ACT_SITE    133    133       Proton donor/acceptor.
FT   ACT_SITE    161    161       Schiff-base intermediate with substrate.
FT   BINDING      45     45       Pyruvate. {ECO:0000255|HAMAP-
FT                                Rule:MF_00418,
FT                                ECO:0000269|PubMed:20353808,
FT                                ECO:0000269|PubMed:22552955}.
FT   BINDING     203    203       Pyruvate; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_00418,
FT                                ECO:0000269|PubMed:20353808,
FT                                ECO:0000269|PubMed:22552955}.
FT   SITE         44     44       Part of a proton relay during catalysis.
FT   SITE         49     49       L-lysine inhibitor binding; via carbonyl
FT                                oxygen.
FT   SITE         80     80       L-lysine inhibitor binding.
FT   SITE         84     84       L-lysine inhibitor binding.
FT   SITE        106    106       L-lysine inhibitor binding.
FT   SITE        107    107       Part of a proton relay during catalysis.
FT   MUTAGEN      44     44       T->S: 8% of wild-type activity. 4-fold
FT                                decrease in affinity for pyruvate, but
FT                                nearly no change in that for (S)-ASA.
FT                                {ECO:0000269|PubMed:15066435,
FT                                ECO:0000269|PubMed:19505526}.
FT   MUTAGEN      44     44       T->V: Reduced kcat by 99.9%.
FT                                {ECO:0000269|PubMed:15066435,
FT                                ECO:0000269|PubMed:19505526}.
FT   MUTAGEN     107    107       Y->F: Reduced kcat by 90%.
FT                                {ECO:0000269|PubMed:15066435,
FT                                ECO:0000269|PubMed:18937497}.
FT   MUTAGEN     107    107       Y->W: Reduced activity by 95%. Reduced
FT                                affinity for both substrates. Exists as a
FT                                mixture of monomer, dimer and tetramer in
FT                                solution. Has significantly lower thermal
FT                                stability than the wild-type enzyme.
FT                                {ECO:0000269|PubMed:15066435,
FT                                ECO:0000269|PubMed:18937497}.
FT   MUTAGEN     133    133       Y->F: Reduced kcat by 99.7%. Reduced
FT                                affinity for both substrates.
FT                                {ECO:0000269|PubMed:15066435}.
FT   MUTAGEN     138    138       R->A,H: Strongly increased KM for L-
FT                                aspartate 4-semialdehyde. No effect on KM
FT                                for pyruvate. Reduced activity by 99.7%.
FT                                {ECO:0000269|PubMed:16185069}.
FT   MUTAGEN     161    161       K->A: 0.1% of wild-type activity. 3-fold
FT                                decrease in affinity for pyruvate, and 2-
FT                                fold decrease in that for (S)-ASA.
FT                                {ECO:0000269|PubMed:20353808}.
FT   MUTAGEN     161    161       K->R: 0.35% of wild-type activity. 3-fold
FT                                decrease in affinity for pyruvate, but
FT                                nearly no change in that for (S)-ASA.
FT                                {ECO:0000269|PubMed:20353808}.
FT   MUTAGEN     197    197       L->Y,D: 1.4 to 2.5% of wild-type
FT                                activity. Decrease in affinity for
FT                                pyruvate, but nearly no change in that
FT                                for (S)-ASA. Exists as a dimer in
FT                                solution. {ECO:0000269|PubMed:18556019}.
FT   CONFLICT    207    207       A -> T (in Ref. 1; AAA23665).
FT                                {ECO:0000305}.
FT   CONFLICT    224    224       G -> E (in Ref. 1; AAA23665).
FT                                {ECO:0000305}.
FT   STRAND        4      8       {ECO:0000244|PDB:2OJP}.
FT   STRAND       17     19       {ECO:0000244|PDB:2PUR}.
FT   HELIX        21     34       {ECO:0000244|PDB:2OJP}.
FT   STRAND       38     43       {ECO:0000244|PDB:2OJP}.
FT   TURN         44     47       {ECO:0000244|PDB:2OJP}.
FT   HELIX        48     50       {ECO:0000244|PDB:2OJP}.
FT   HELIX        53     67       {ECO:0000244|PDB:2OJP}.
FT   STRAND       73     76       {ECO:0000244|PDB:2OJP}.
FT   HELIX        82     91       {ECO:0000244|PDB:2OJP}.
FT   TURN         92     94       {ECO:0000244|PDB:2OJP}.
FT   STRAND       98    103       {ECO:0000244|PDB:2OJP}.
FT   HELIX       112    123       {ECO:0000244|PDB:2OJP}.
FT   STRAND      130    133       {ECO:0000244|PDB:2OJP}.
FT   HELIX       136    139       {ECO:0000244|PDB:2OJP}.
FT   HELIX       145    152       {ECO:0000244|PDB:2OJP}.
FT   STRAND      157    160       {ECO:0000244|PDB:2OJP}.
FT   HELIX       169    174       {ECO:0000244|PDB:2OJP}.
FT   STRAND      181    186       {ECO:0000244|PDB:2OJP}.
FT   HELIX       188    190       {ECO:0000244|PDB:2OJP}.
FT   HELIX       191    196       {ECO:0000244|PDB:2OJP}.
FT   STRAND      201    205       {ECO:0000244|PDB:2OJP}.
FT   HELIX       206    208       {ECO:0000244|PDB:2OJP}.
FT   HELIX       211    222       {ECO:0000244|PDB:2OJP}.
FT   HELIX       226    242       {ECO:0000244|PDB:2OJP}.
FT   STRAND      245    247       {ECO:0000244|PDB:2OJP}.
FT   HELIX       250    258       {ECO:0000244|PDB:2OJP}.
FT   STRAND      261    263       {ECO:0000244|PDB:2OJP}.
FT   HELIX       276    288       {ECO:0000244|PDB:2OJP}.
SQ   SEQUENCE   292 AA;  31270 MW;  3970543296A77C08 CRC64;
     MFTGSIVAIV TPMDEKGNVC RASLKKLIDY HVASGTSAIV SVGTTGESAT LNHDEHADVV
     MMTLDLADGR IPVIAGTGAN ATAEAISLTQ RFNDSGIVGC LTVTPYYNRP SQEGLYQHFK
     AIAEHTDLPQ ILYNVPSRTG CDLLPETVGR LAKVKNIIGI KEATGNLTRV NQIKELVSDD
     FVLLSGDDAS ALDFMQLGGH GVISVTANVA ARDMAQMCKL AAEGHFAEAR VINQRLMPLH
     NKLFVEPNPI PVKWACKELG LVATDTLRLP MTPITDSGRE TVRAALKHAG LL
//
